Clinical Trials · NCT06162715

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Active Not RecruitingPhase 2/Phase 3Tirzepatide (Investigational)
Phase
Phase 2/Phase 3
Recruitment status
Active Not Recruiting
Sponsor
Vanderbilt University Medical Center
Enrollment
30
Start date
Oct 2024
Locations
1 site, United States
Primary endpoint
Weight loss
View Tirzepatide compound reference